Episode 19 | 37:02 min

Partnering For Good

Episode 19 | 37:02 min | 12.15.2021

Partnering For Good

00:00

This is a podcast episode titled, Partnering For Good. The summary for this episode is: <a href="https://www.linkedin.com/in/timlancaster/" rel="noopener noreferrer" target="_blank">Tim Lancaster</a> of <a href="https://www.indigobio.com/home" rel="noopener noreferrer" target="_blank">Indigo BioAutomation</a> and <a href="https://www.linkedin.com/in/mark-perkins-05527927/" rel="noopener noreferrer" target="_blank">Mark Perkins</a> of <a href="https://www.bindingsite.com/en" rel="noopener noreferrer" target="_blank">The Binding Site</a> join us to share how they're bringing artificial intelligence and mass spectrometry together to make significant improvements in the world of multiple myeloma.Mark's team saw a massive opportunity to improve multiple myeloma diagnostics, but they knew they needed a software partner. Tim's team at Indigo Bioautomation proved to be the perfect fit. Mark and Tim share about their powerful partnership and their journey from turning an idea to a tool that will change patients' lives.You can find more information about this podcast at <a href="https://app.casted.us/account/62/shows/81b7557b-52e8-4ea3-87b9-a8f2cdaa00e4/episodes/93ecce9c-0530-4661-a507-b77e2748f4ee/sep.com/podcast" rel="noopener noreferrer" target="_blank">sep.com/podcast</a> and subscribe wherever you get your podcasts. Thanks for listening!

Tim Lancaster

|Executive Vice President of Strategy and Technology at Indigo BioAutomation

Tim’s career has focused on providing leading edge software to the life science and medical industry. As Executive Vice President of Product Development, Tim is responsible for the design, development, delivery, and production operation of Indigo’s software products. Tim has hands-on experience in the construction of complex software using a wide variety of technologies and processes. Tim brings a constant drive to improve and a history of identifying and leading tactical and strategic changes to help the whole team succeed.

Tim's LinkedIn

Mark Perkins

|Global Head of Mass Spectrometry - Business Development at The Binding Site

Mark has a PhD in pharmaceutical studies and spent the first 10 years of his career in the pharmaceutical industry before he moved into diagnostics. In his current role as the Global Head of Mass Spectrometry - Business Development at The Binding Site, Mark leads commercial and research development for a new product line. He loves seeing products come to life and go to market.

Mark's LinkedIn

Takeaway 1 | 01:19 MIN

Mark explains the need for a software partner.

Takeaway 2 | 01:07 MIN

Mark shares about how the product idea was born and the need for automation.

Takeaway 3 | 00:37 MIN

Tim shares the benefits of software in a precise process like multiple myeloma diagnosis.

Takeaway 4 | 00:50 MIN

Mark explains how EXENT-IQ is game-changing for multiple myeloma diagnostics.

Takeaway 5 | 00:36 MIN

Mark shares how the team has developed the user experience of EXENT-IQ.

Takeaway 6 | 00:51 MIN

Tim discusses the joint team's approach to user-forcused product development.

Takeaway 7 | 01:13 MIN

Tim explains how technology can make collaborative processes easier.

Tim Lancaster of Indigo BioAutomation and Mark Perkins of The Binding Site join us to share how they're bringing artificial intelligence and mass spectrometry together to make significant improvements in the world of multiple myeloma.

Mark's team saw a massive opportunity to improve multiple myeloma diagnostics, but they knew they needed a software partner. Tim's team at Indigo Bioautomation proved to be the perfect fit. Mark and Tim share about their powerful partnership and their journey from turning an idea to a tool that will change patients' lives.

You can find more information about this podcast at sep.com/podcast and subscribe wherever you get your podcasts. Thanks for listening!